Mami Miura

Title: Mami Miura: Innovator in Pharmaceutical Chemistry

Introduction

Mami Miura is a prominent inventor based in Nara, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. With a total of 2 patents, her work focuses on innovative solutions for various health conditions.

Latest Patents

Mami Miura's latest patents include the development of fused azole-pyrimidine derivatives. These compounds exhibit enhanced potency for phosphatidylinositol-3-kinase (PI3K) inhibition, especially targeting PI3K-γ. The applications of these derivatives are extensive, as they can be used for the prophylaxis and treatment of diseases associated with PI3K activity. This includes inflammatory and immunoregulatory disorders such as asthma, atopic dermatitis, and chronic obstructive pulmonary disease (COPD). Additionally, they are relevant in treating cancer, heart failure, and neurodegenerative disorders like Parkinson's and Alzheimer's diseases.

Career Highlights

Throughout her career, Mami Miura has worked with notable organizations, including Bayer Pharmaceuticals Corporation and Bayer Pharma Aktiengesellschaft. Her experience in these companies has allowed her to refine her expertise in pharmaceutical innovations and contribute to significant advancements in drug development.

Collaborations

Mami Miura has collaborated with esteemed colleagues such as Mitsuyuki Shimada and Toshiki Murata. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.

Conclusion

Mami Miura's contributions to pharmaceutical chemistry through her innovative patents and collaborations highlight her role as a key inventor in the field. Her work continues to impact the treatment of various diseases, showcasing the importance of innovation in healthcare.